Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSE - Gold, R; Arnold, DL; Bar-Or, A; Fox, RJ; Kappos, L; Chen, C (Ther Adv Neurol Disord, 2020)
May 12;13:1756286420915005